Circulation, Vol 88, 2123-2127, Copyright © 1993 by American Heart Association
FJ Ten Cate, P Widimsky, JH Cornel, DJ Waldstein, PW Serruys and A Waaler
BACKGROUND. Albunex is a recently developed ultrasonic contrast agent made
from sonicated human serum albumin. The effects on left ventricular
hemodynamics, function, and coronary sinus flow of intracoronary Albunex in
humans have not been reported. METHODS AND RESULTS. Eighteen patients with
known or suspected coronary artery disease were examined at the time of
coronary arteriography with simultaneous two-dimensional echocardiography
and left ventricular catheter-tip manometry. Intracoronary injections of
Albunex into the left main coronary artery were performed, as were
injections of 5% human serum albumin and iohexol, a widely used
angiographic contrast agent. Mean coronary sinus flow was determined before
and after injections of iohexol and 2 mL of Albunex. Injection of 1 mL of
Albunex induced no changes in any of the measured hemodynamic parameters
(heart rate, peak left ventricular [LV] systolic pressure, LV end-diastolic
pressure, positive or negative LV dP/dt, or time constant of relaxation) or
echocardiographic determinants of LV function (regional wall motion and
global ejection fraction). Injection of 2 mL or more of Albunex caused
small, transient (less than 30 seconds) changes in measures of isovolumic
relaxation (negative LV dP/dt; 95% confidence interval: mean, -2.41 [-4.3,
-0.52] and tau 1; confidence interval mean, 3.52; [1.48, 5.58]) but not in
functional measures. Intracoronary injection of 5% human serum albumin had
no effect. Iohexol induced small but significant changes in both systolic
and diastolic parameters, which lasted beyond 30 seconds after injection.
Mean coronary sinus blood flow increased. CONCLUSIONS. The effects of
Albunex on hemodynamics, left ventricular function, and coronary sinus
blood flow compare favorably with iohexol. Albunex can be considered to be
an essentially inert contrast agent if used in patients with stable
coronary artery disease.
ARTICLES
Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans
Department of Cardiology, University Hospital Dijkzigt, The Netherlands.
This article has been cited by other articles:
![]() |
F. F. Immer, A. M. Seiler, B. C. Aeschbacher, F. Mahler, H. Saner, and H. Saner Influence of the Ultrasound Contrast Agent Levovist(R) on Human Nailfold Capillary Microcirculation Angiology, February 1, 2000; 51(2): 123 - 129. [Abstract] [PDF] |
||||
![]() |
K. C. Wu, R. J. Kim, D. A. Bluemke, C. E. Rochitte, E. A. Zerhouni, L. C. Becker, and J. A. C. Lima Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1756 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Van Liew and S. Raychaudhuri Stabilized bubbles in the body: pressure-radius relationships and the limits to stabilization J Appl Physiol, June 1, 1997; 82(6): 2045 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sklenar, G. Camarano, N. C. Goodman, S. Ismail, A. R. Jayaweera, and S. Kaul Contractile Versus Microvascular Reserve for the Determination of the Extent of Myocardial Salvage After Reperfusion: The Effect of Residual Coronary Stenosis Circulation, September 15, 1996; 94(6): 1430 - 1440. [Abstract] [Full Text] |
||||
![]() |
F. S. Villanueva, G. Camarano, S. Ismail, N. C. Goodman, J. Sklenar, and S. Kaul Coronary Reserve Abnormalities in the Infarcted Myocardium: Assessment of Myocardial Viability Immediately Versus Late After Reflow by Contrast Echocardiography Circulation, August 15, 1996; 94(4): 748 - 754. [Abstract] [Full Text] |
||||
![]() |
S. Ismail, A. R. Jayaweera, G. Camarano, L. W. Gimple, E. R. Powers, and S. Kaul Relation Between Air-Filled Albumin Microbubble and Red Blood Cell Rheology in the Human Myocardium: Influence of Echocardiographic Systems and Chest Wall Attenuation Circulation, August 1, 1996; 94(3): 445 - 451. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |